This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: Chiesi Farmaceutici S.p.a., Zymenex A/s. Active years: 2015-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2018
Title: Helena Reuterwall: Innovator in Recombinant Enzyme Production
Introduction
Helena Reuterwall is a prominent inventor based in Solna, Sweden. She has made significant contributions to the field of biochemistry, particularly in the production and purification of recombinant enzymes. With a total of 2 patents, her work has the potential to impact medical treatments for genetic disorders.
Latest Patents
Helena's latest patents focus on a process for the production and purification of recombinant lysosomal alpha-mannosidase. This invention relates to the purification of recombinant alpha-mannosidase, a process for its production, and a composition comprising this enzyme. The composition is intended for use as a medicament, specifically for the treatment of alpha-mannosidosis. Additionally, her work includes methods for alleviating the symptoms associated with this condition.
Career Highlights
Throughout her career, Helena has worked with notable companies in the pharmaceutical industry. She has been associated with Chiesi Farmaceutici S.p.a. and Zymenex A/S, where she has contributed her expertise in enzyme production and purification.
Collaborations
Helena has collaborated with several professionals in her field, including Pia Hydén and Stefan Nilsson. These partnerships have enhanced her research and development efforts, leading to innovative solutions in enzyme therapy.
Conclusion
Helena Reuterwall's contributions to the field of recombinant enzyme production are noteworthy. Her patents and collaborations reflect her commitment to advancing medical treatments for genetic disorders. Her work continues to inspire future innovations in biochemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile